A Retrospective Study of the Safety and Immunogenicity of MVC-COV1901 Vaccine for People Living with HIV

A Retrospective Study of the Safety and Immunogenicity of MVC-COV1901 Vaccine for People Living with HIV

Background: This study aimed to assess the safety and immunogenicity of MVC-COV1901, a recombinant COVID-19 protein vaccine, containing S-2P protein adjuvanted with CpG 1018 and aluminum hydroxide, for people living with HIV (PWH). Methods: A total of 57 PWH of ≥20 years of age who are on stable ant...

Full description

Bibliographic Details
Main Authors: Shu-Hsing Cheng, Chia En Lien, Szu-Min Hsieh, Chien-Yu Cheng, Wang-Da Liu, Ching-Lung Lo, Wen-Chien Ko, Yen-Hsu Chen, Ching-Tai Huang, Hsiao-Ting Chang, Shinn-Jang Hwang, Ning-Chi Wang, Ming-Che Liu, Yu-Lin Lee, I-Chen Tai, Josue Antonio Garcia Estrada, Tzou-Yien Lin, Wen-Sen Lee
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Vaccines
Subjects:
COVID-19 vaccine
CpG 1018
S-2P protein
HIV
CD4/CD8 ratio
immunogenicity
Online Access:https://www.mdpi.com/2076-393X/11/1/18

Internet

https://www.mdpi.com/2076-393X/11/1/18

Similar Items